GB0911215D0 - Gamma globin therapy - Google Patents
Gamma globin therapyInfo
- Publication number
- GB0911215D0 GB0911215D0 GB0911215A GB0911215A GB0911215D0 GB 0911215 D0 GB0911215 D0 GB 0911215D0 GB 0911215 A GB0911215 A GB 0911215A GB 0911215 A GB0911215 A GB 0911215A GB 0911215 D0 GB0911215 D0 GB 0911215D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapy
- gamma globin
- globin
- gamma
- globin therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0911215A GB0911215D0 (en) | 2009-06-29 | 2009-06-29 | Gamma globin therapy |
PCT/EP2010/003854 WO2011000516A2 (en) | 2009-06-29 | 2010-06-29 | Gamma globin therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0911215A GB0911215D0 (en) | 2009-06-29 | 2009-06-29 | Gamma globin therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0911215D0 true GB0911215D0 (en) | 2009-08-12 |
Family
ID=41008427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0911215A Ceased GB0911215D0 (en) | 2009-06-29 | 2009-06-29 | Gamma globin therapy |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0911215D0 (en) |
WO (1) | WO2011000516A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112986589B (en) * | 2017-01-05 | 2023-01-24 | 深圳迈瑞生物医疗电子股份有限公司 | Reticulocyte mimic particle, platelet mimic particle preparation method and quality control material |
CN111638261B (en) * | 2020-04-17 | 2023-04-07 | 融智生物科技(青岛)有限公司 | Computing equipment, storage medium and thalassemia screening device and system |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US5175385A (en) | 1987-09-03 | 1992-12-29 | Ohio University/Edison Animal Biotechnolgy Center | Virus-resistant transgenic mice |
US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
WO1991010741A1 (en) | 1990-01-12 | 1991-07-25 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
CA2174737C (en) | 1993-10-29 | 2008-04-22 | Douglas V. Faller | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
US6403647B1 (en) | 1996-07-26 | 2002-06-11 | Susan P. Perrine | Pulsed administration of compositions for the treatment of blood disorders |
GB2344886B (en) | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
US8273866B2 (en) | 2002-02-20 | 2012-09-25 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA) |
EP1425694A2 (en) | 2001-08-03 | 2004-06-09 | Medical Research Council | Method of identifying a consensus sequence for intracellular antibodies |
GB0226727D0 (en) | 2002-11-15 | 2002-12-24 | Medical Res Council | Intrabodies |
AU2003219277A1 (en) | 2002-03-14 | 2003-09-29 | Medical Research Council | Intracellular antibodies |
ITTO20020684A1 (en) | 2002-07-31 | 2004-02-01 | Associazione Veneta Per La Lotta Alla Talassemia | NEW USE OF ANGELICINA AND ITS STRUCTURAL ANALOGUES. |
GB0226729D0 (en) | 2002-11-15 | 2002-12-24 | Medical Res Council | Intracellular antibodies |
WO2005011696A1 (en) | 2003-08-01 | 2005-02-10 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
WO2007140335A2 (en) * | 2006-05-25 | 2007-12-06 | The Regents Of The University Of Michigan | Screening methods and transgenic animals for treatment of beta-globin related diseases and conditions |
-
2009
- 2009-06-29 GB GB0911215A patent/GB0911215D0/en not_active Ceased
-
2010
- 2010-06-29 WO PCT/EP2010/003854 patent/WO2011000516A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011000516A2 (en) | 2011-01-06 |
WO2011000516A3 (en) | 2011-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL222778A0 (en) | Diabetes therapy | |
IL222481A0 (en) | Combination therapy | |
ZA201303499B (en) | Specific diarylhydantoin and diarylthiohydantion compounds | |
EP2552323A4 (en) | Combination therapy | |
EP2417591A4 (en) | Reducing medical error | |
PT2389212T (en) | Syringe | |
IL206654A0 (en) | Combination therapy | |
EP2543336A4 (en) | Articulator | |
IL215481A0 (en) | Improved glucocorticoid therapy | |
EP2427183A4 (en) | Therapeutic compounds | |
GB201015822D0 (en) | Medical ruggedised case | |
EP2496704A4 (en) | Therapeutic compounds | |
GB201005394D0 (en) | Therapy | |
GB0908425D0 (en) | Medical use | |
EP2515645A4 (en) | Antifungal therapy | |
GB0916997D0 (en) | Combination therapy | |
GB0911215D0 (en) | Gamma globin therapy | |
GB0803948D0 (en) | Combination therapy | |
GB0907973D0 (en) | Combination therapy | |
EP2456309A4 (en) | Therapeutic compounds | |
GB0906026D0 (en) | Therapeutic compounds | |
GB0922316D0 (en) | Syringe | |
GB0921244D0 (en) | Therapy | |
GB0914820D0 (en) | WATerian therapy | |
GB0903321D0 (en) | Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |